Genmab (GMAB) Event Aug. 05, 2022, 03:47 UTC 102 0 comments Genmab and BioNTech Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates Comment Full text
Forma Therapeutics Holdings Inc (the company became a subdivision of the company Novo Nordisk (NYSE: NVO)) (FMTX) Event Aug. 05, 2022, 00:00 UTC 49 1 comments (61% Neutral) Forma Therapeutics Holdings, Inc. (FMTX) Reports Net Loss for 2022-06-30 Comment Full text
BioCryst Pharmaceuticals Inc (BCRX) Event Aug. 05, 2022, 00:00 UTC 51 1 comments (51% Neutral) BIOCRYST PHARMACEUTICALS, INC. (BCRX) Reports Net Loss for 2022-06-30 Comment Full text
Immunovant Inc (IMVT) Event Aug. 05, 2022, 00:00 UTC 61 1 comments (66% Neutral) IMMUNOVANT, INC. (IMVT) Reports Net Loss for 2022-06-30 Comment Full text
Arcutis Biotherapeutics (ARQT) Event Aug. 04, 2022, 21:25 UTC 29 1 comments (30% Negative) ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Reports Q3 2022 Financial Results Comment Full text
Keros Therapeutics Inc (KROS) Event Aug. 04, 2022, 21:13 UTC 25 1 comments (10% Negative) Keros Therapeutics, Inc. (KROS) Announces Delay in trials Trials for KER-050 Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Poseida Therapeutics (PSTX) Event Aug. 04, 2022, 20:57 UTC 31 1 comments (99% Neutral) Poseida Therapeutics, Inc. (PSTX) Files Form 8-K Comment Full text
BridgeBio Pharma (BBIO) Event Aug. 04, 2022, 20:43 UTC 27 1 comments (10% Negative) BridgeBio Pharma, Inc. (BBIO) Reports Q3 2022 Financial Results Comment Full text
Sana Biotechnology Inc (SANA) Event Aug. 04, 2022, 20:42 UTC 27 1 comments (30% Negative) SANA BIOTECHNOLOGY, INC. (SANA) Reports Q3 2022 Financial Results Comment Full text
Gritstone Oncology Inc (GRTS) Event Aug. 04, 2022, 20:41 UTC 31 1 comments (30% Negative) Gritstone bio, Inc. (GRTS) Reports Q3 2022 Financial Results Comment Full text